Saint Vincent and the Grenadines vs Yemen: Previously treated cases tested for RR-/MDR-TB
Saint Vincent and the Grenadines
100.0%
in 2022
Yemen
100.0%
in 2024
Saint Vincent and the Grenadines rank
1st
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Saint Vincent and the Grenadines
- Yemen
How they compare
Saint Vincent and the Grenadines currently reports 100.0% against 100.0% in Yemen, a difference of 0.0%.
The two have swapped places 3 times across 5 shared years of data; in 2012 it was Yemen ahead.
Saint Vincent and the Grenadines ranks 1st and Yemen ranks 1st of 180 countries.
Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 33.3% | 25.4% | 8.0% | Saint Vincent and the Grenadines |
| 2020s | 50.0% | 47.5% | 2.5% | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Saint Vincent and the Grenadines or Yemen?
- Saint Vincent and the Grenadines, at 100.0% against 100.0% in Yemen as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Saint Vincent and the Grenadines and Yemen?
- 0.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Yemen?
- 5 years are reported by both, from 2012 to 2022.
- How do Saint Vincent and the Grenadines and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Saint Vincent and the Grenadines ranks 1st and Yemen ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.